New scan-guided radiation aims to cut side effects in recurrent prostate cancer

NCT ID NCT07234981

Recruiting now Disease control Sponsor: University of Nebraska Source: ClinicalTrials.gov ↗

First seen Nov 19, 2025 · Last updated May 16, 2026 · Updated 24 times

Summary

This study tests whether using a special PET scan (PSMA-PET) to guide radiation can safely reduce the dose and side effects in men whose prostate cancer has returned after surgery. About 54 men will receive a lower amount of radiation to the pelvis plus a focused boost to the cancer spots seen on the scan, along with standard hormone therapy. The main goal is to see if this approach causes fewer moderate-to-severe short-term side effects compared to historical rates, while still keeping the cancer under control.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Nebraska Medical Center
RECRUITING

Omaha, Nebraska, 68198, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

PROSTATE CANCER